BioSpace News Archive

Business

Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base

Company also announces participation in BioJapan 2019, one of Asia’s largest partnering events for the global biotechnology industry, October 9-11, 2019 in Pacifico Yokohama

October 6, 2019
·
3 min read
Drug Development

Biophytis Opens 22nd Clinical Site in the SARA-INT Phase 2b Trial of Sarconeos (BIO101) for the Treatment of Sarcopenia

Target number of clinical sites reached, including leading hospitals and geriatric centers in the US and Europe Patient enrollment expected to complete in mid-2020

October 6, 2019
·
6 min read
Deals

Promore Pharma Promore Pharma carries out a rights issue of approximately SEK 75 million, underwritten up to 80 percent, and intends to publish its interim report early

The Board of Directors of Promore Pharma AB has resolved to carry out a new share issue with preferential rights for the Company’s existing shareholders of a total of SEK 75 million excluding transaction costs.

October 6, 2019
·
11 min read
Drug Development

Fulcrum Therapeutics announces Phase 1 results of losmapimod in treatment of FSHD at the World Muscle Society Meeting

Data presented in an oral presentation at World Muscle Society meeting highlighted safety, tolerability, pharmacokinetics and target engagement of losmapimod in patients with facioscapulohumeral dystrophy.

October 6, 2019
·
7 min read
Pharm Country

NIH Grant Awarded to Akelos Collaborator, Funds Work to Develop Non-Opioid Drugs for Neuropathic Pain

A grant from the National Institutes of Health awarded to a Weill Cornell Medicine investigator will bolster Akelos Inc.-supported research to develop a non-opioid alternative to treat chronic and neuropathic pain.

October 6, 2019
·
3 min read
Drug Development

Chi-Med Initiates an International Phase I/Ib Trial of HMPL-523 in Patients with Advanced Relapsed or Refractory Lymphoma

Hutchison China MediTech Limited has initiated an international Phase I/Ib study of HMPL-523, its novel spleen tyrosine kinase inhibitor, in patients with relapsed or refractory lymphoma.

October 6, 2019
·
4 min read
GENEWIZ Celebrates Opening of European Headquarters in Germany

Leading global genomics services provider, GENEWIZ, a Brooks Life Sciences Company, announced the opening of its European headquarters for its genomics business in Leipzig, Germany.

October 6, 2019
·
4 min read
Canadians raise $17 million at the Canadian Cancer Society CIBC Run for the Cure

Funds raised benefit breast cancer research and the country’s largest support system for people facing breast cancer

October 6, 2019
·
3 min read
Business

MIMETAS and Hubrecht Organoid Technologies to Develop and Market Organoids-on-a-Chip

MIMETAS and Hubrecht Organoid Technologies (HUB) announce that they entered into a strategic collaboration to market organoid models on a Chip

October 6, 2019
·
3 min read